Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Decreases By 40.7%

Clearmind Medicine Inc. (NASDAQ:CMND) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 187,600 shares, a drop of 40.7% from the October 31st total of 316,600 shares. Approximately 6.2% of the shares of the stock are short sold. Based on an average trading volume of 258,000 shares, the days-to-cover ratio is presently 0.7 days.

Clearmind Medicine Trading Down 3.8 %

Shares of NASDAQ CMND traded down $0.05 during mid-day trading on Thursday, reaching $1.28. The company had a trading volume of 61,198 shares, compared to its average volume of 1,313,104. The company has a 50-day moving average price of $1.37 and a two-hundred day moving average price of $1.36. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.71 and a current ratio of 1.71. Clearmind Medicine has a 1-year low of $0.92 and a 1-year high of $6.80.

Clearmind Medicine (NASDAQ:CMND) last issued its quarterly earnings results on Monday, September 16th. The company reported ($0.59) earnings per share for the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Clearmind Medicine stock. AdvisorShares Investments LLC increased its position in Clearmind Medicine Inc. (NASDAQ:CMND) by 14.2% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 128,641 shares of the company’s stock after purchasing an additional 15,948 shares during the period. AdvisorShares Investments LLC owned about 7.60% of Clearmind Medicine worth $214,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 96.05% of the company’s stock.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.